Guide
Why the generic version may not be actionable
This is the rule most people find hardest to accept, and it's worth understanding properly rather than being surprised by it later.
Published July 27, 2026 · Last reviewed July 30, 2026
The doctrine
Federal law requires a generic drug's labeling to match the brand-name reference drug's labeling. A generic manufacturer cannot unilaterally strengthen a warning — doing so would violate federal law.
In PLIVA v. Mensing (2011), the Supreme Court held that because generic manufacturers cannot independently change their labels, state-law failure-to-warn claims against them are preempted. Two years later, in Mutual Pharmaceutical v. Bartlett, the Court extended similar reasoning to design defect claims where the practical remedy would have been a label change.
Brand-name manufacturers are in a different position. They control their labeling and can strengthen warnings as evidence emerges, so failure-to-warn claims against them are generally not preempted — a distinction the Court drew in Wyeth v. Levine (2009).
| Claim | Brand manufacturer | Generic manufacturer |
|---|---|---|
| Failure to warn | Generally available | Largely preempted |
| Design defect | Generally available | Largely preempted |
| Manufacturing defect | Available | Available |
| Failure to update label after brand did | N/A | Available |
| Failure to pass on a brand warning | N/A | Available |
What survives against a generic manufacturer
Preemption is not total, and several theories remain available.
- Manufacturing defect claims, where the product deviated from its own specifications — contamination, impurities, potency errors. Federal law never required them to ship a defective product
- Failure to update the label after the brand did, since generics are required to keep pace with brand label changes
- Failure to communicate warnings the brand did communicate, such as omitted dear-doctor letters
- Claims where the brand manufacturer discontinued the drug and the generic maker took over responsibility for the label
- Claims against a distributor, repackager, or pharmacy on other theories
Find out what you were dispensed
Most people don't know, because pharmacies substitute automatically in most states unless a prescriber blocks it.
Your pharmacy dispensing record settles it. It lists the manufacturer and the NDC number for every fill, and NDC identifies the specific labeler and product. Request the complete history for the entire period you took the drug, from every pharmacy you used.
It's very common to find a mixed history — brand for a period, then generic after a formulary change, then a different generic manufacturer after that. Which periods were which can determine whether a claim exists at all, and which manufacturers are defendants.
The brand-manufacturer-for-generic-injury theory
A minority of states have allowed claims against a brand manufacturer by someone who took the generic, on the theory that the brand controlled the label everyone relied on. Most states have rejected it.
It's a genuinely unsettled area and worth asking about in your state. Don't assume either way.
Questions
This seems unfair.
It's been widely criticized, including from the bench. It arises from the interaction between the federal generic approval framework and state tort law, and only Congress or the Court can change it. Understanding it saves you from finding out at month six.
How do I read my dispensing record?
Look for the labeler or manufacturer name and the NDC number on each fill. If it names the brand company and matches the brand NDC, you received brand. Most other entries indicate a generic. A pharmacist can confirm.
I took the brand for a while and then the generic.
Common, and it matters. Claims may exist for the brand period, and whether that's enough depends on when the injury developed and what your treatment records show about timing. The dispensing history is what makes this analysis possible.
Situations this applies to
A prescription drug harmed me
The hardest claim here. Whether it's viable often turns on brand versus generic.
Read this
The pharmacy made an error
The most provable claim here. The error is documented and preemption doesn't apply.
Read this
An implant or device failed
How the FDA cleared the device usually decides whether you can sue at all.
Read this
My medication was recalled
Contamination claims sidestep the preemption problem entirely.
Read thisRelated guides
Evidence and research resources
See all resourcesEvidence checklist
The records, objects, photographs, and timelines worth preserving now.
Read thisPlain-language glossary
Medical, insurance, safety, and legal terms explained without the jargon.
Read thisOfficial sources
The government, court, safety, and medical sources used to check this site.
Read thisGet a straight answer about your case
Reading only gets you so far. A free review puts your actual facts in front of an attorney who handles these claims.
Free · No obligation · About 90 seconds